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Abstract
The major histocompatibility complex (MHC) class I genes play a critical role within the immune system, both by the
presentation of antigens from intracellular pathogens to immunocompetent cells and by the interaction with killer cell
immunoglobulin-like receptors (KIR) on natural killer cells (NK cells). Genes of the MHC are highly diverse, and MHC
variation can have effects on the immune functionality of individuals; hence, comparisons of MHC diversity among
closely related phylogenetic taxa may give insight into the factors responsible for the shaping of its diversity. The four
geographically separated chimpanzee subspecies differ in their overall genetic diversity, have different population
histories, and are confronted with different pathogens in their natural habitat, all of which may affect MHC class I
DNA sequence diversity. Here, we compare the MHC-B exon two DNA sequence diversity from 24 wild western and 46
wild eastern chimpanzees using necropsy and noninvasively collected fecal samples, respectively. We found a higher
MHC-B exon two nucleotide diversity, in our western than eastern chimpanzees. The inclusion of previously published
MHC-B exon two data from other western and eastern chimpanzees supported this finding. In addition, our results
confirm and extend the finding of a very low C1 epitope frequency at eastern chimpanzee MHC-B molecules, which
likely affects the ability of these molecules to interact with NK cells. While the understanding of the differing pathogen
environments encountered by disparate populations of a species is a challenging endeavor, these findings highlight the
potential for these pathogens to selectively shape immune system variation.
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Introduction
The mammalian immune system is critically dependent on
genes of the major histocompatibility complex (MHC), which
encodes for cellular surface proteins responsible for the pre-
sentation of antigens to immunocompetent cells (Townsend
and Bodmer 1989). Two different classes of MHC molecules
can be distinguished. MHC class II molecules are involved in
the presentation of extracellular antigens and thus defend
against extracellular pathogens. In contrast, MHC class I mol-
ecules defend against intracellular pathogens by presenting
antigens mostly derived from viral proteins or cancer-
infected cells (reviewed in Rock et al. 2016; Sommer 2005).
Along with their role in antigen presentation to T cells, MHC
class I molecu les a l so in te rac t wi th k i l l e r ce l l
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immunoglobulin-like receptors (KIR) occurring on natural
killer cells (NK cells) (Parham 2005; Parham et al. 2010).
NK cell responses are the result of a balance of stimulating
and inhibiting signals derived from cell surface receptors like
KIRs (Lanier 2003). In the case of viral infection, cells can
lose expression of MHC class I molecules and thereby the
ability to present antigens to T cells as well as the ability to
interact with KIRs inhibiting NK cell activation, making such
infected cells targets for NK cell lysis (Hoglund and Brodin
2010). Thus, the NK cell responses substantially support the
defense against viral infections by contributing to the innate
immunity (Waggoner et al. 2016; Wroblewski et al. 2019).
Relative to protein-coding genes in the rest of the genome,
MHC class I genes display an extreme degree of polymor-
phism. Thousands of alleles have been described for the three
classical MHC class I genes in humans, designated asHLA-A,
HLA-B, and HLA-C, with the B locus having the largest num-
ber of described alleles (Robinson et al. 2015). Different
mechanisms have been proposed to explain the extraordinarily
high diversity at MHC loci, mainly focusing on pathogen-
mediated selection (Bernatchez and Landry 2003; Doherty
and Zinkernagel 1975; Jeffery and Bangham 2000; Spurgin
and Richardson 2010). This is the idea that a high diversity of
alleles is a response to the high diversity of pathogens typical-
ly encountered and that changes in pathogen exposure may
drive changes in allele frequencies in populations due to dif-
ferential survival of individuals.
Comparison of variation at the MHC for humans and our
closest living relatives, the African apes, has revealed remark-
able differences in lineage and allelic diversity that are thought
to be linked to selective sweeps in the past. For example, both
the bonobo (Pan paniscus) and chimpanzee (Pan troglodytes)
lack the A2 lineage of MHC-A and exhibit lower diversity in
MHC class I introns, which are suggested to be result from a
selective event driven by lentivirus exposure some 2 million
years ago (Ma), before these congeners speciated (Adams
et al. 2000; de Groot et al. 2000; de Groot et al. 2002;
Lawlor et al. 1995; McAdam et al. 1995). There is further
evidence of functional differences inMHC-B in bonobos com-
pared to chimpanzees, which are attributed to selective pro-
cesses and/or a severe bottleneck in ancestral bonobos since
the divergence of these two taxa (Maibach and Vigilant 2019;
Wroblewski et al. 2017). The MHC-B locus is of particular
interest because of its role in HIV disease progression in
humans (Carrington and O’Brien 2003; Fellay et al. 2007;
Goulder et al. 1996; Kiepiela et al. 2004; Matzaraki et al.
2017; Naranbhai and Carrington 2017) and simian immuno-
deficiency virus (SIVcpz) infection in chimpanzees
(Wroblewski et al. 2015).
Genetic analysis of the four geographically defined chim-
panzee subspecies P. t. verus (western chimpanzees), P. t.
ellioti (Nigerian-Cameroon chimpanzees), P. t. troglodytes
(central chimpanzees), and P. t. schweinfurthii (eastern
chimpanzees) has shown that they have different degrees of
genetic diversity, and experienced different demographic his-
tories (Becquet et al. 2007; Fischer et al. 2006; Fischer et al.
2004; Hey 2010; Prado-Martinez et al. 2013; Wegmann and
Excoffier 2010). The western subspecies was the first to di-
verge from the ancestral population, approximately 500,000
years ago, and the most recent split was between the eastern
and central subspecies (Becquet et al. 2007; Caswell et al.
2008; Hey 2010; Prado-Martinez et al. 2013; Wegmann and
Excoffier 2010). The long history of subspecies separations,
and potentially differing pathogenic environments in their
habitats, could have led to different levels of MHC diversity
and allele compositions in the subspecies.
Indeed, a specific example of how pathogen pressure may
differ among populations is provided by the distribution of
SIVcpz, a virus related to HIV which can also cause AIDS-
like symptoms and increase mortality in infected apes
(Barbian et al. 2017; Keele et al. 2009; Sharp and Hahn
2011). SIVcpz has been detected in the wild only in central
and eastern chimpanzees (Heuverswyn et al. 2007; Keele et al.
2006; Prince et al. 2002; Rudicell et al. 2010; Santiago et al.
2003; Santiago et al. 2002; Sharp and Hahn 2011; Sharp et al.
2005; Worobey et al. 2004). Evidence that SIVcpz can influ-
ence MHC diversity and allele composition of a population or
community comes from a study investigating SIVcpz preva-
lence in three neighboring eastern chimpanzee communities,
which detected changes in theMHC-B allele composition of a
community over a 15-year period (Wroblewski et al. 2015).
Although apparently not subject to infection by SIVcpz, sev-
eral neighboring communities of western chimpanzees have
experienced Ebola virus outbreaks and anthrax infections,
pathogens to date not reported in eastern chimpanzees, pro-
viding further potential for differential exposure to pathogens
to shape immune responses (Formenty et al. 1999; Hoffmann
et al. 2017; Leendertz et al. 2004; Leendertz et al. 2017).
In chimpanzees, three different KIR epitopes have been
described within the α1 protein domain of the exon two of
MHC-B and -C molecules (Parham and Moffett 2013;
Wroblewski et al. 2015; Wroblewski et al. 2019). MHC-B
molecules may have none, the Bw4 or the C1 (MHC-B-C1)
epitope, whereby MHC-C molecules have either the C1
(MHC-C-C1) or the C2 epitope (Parham and Moffett 2013;
Wroblewski et al. 2015; Wroblewski et al. 2019). Those KIR
epitopes interact with KIRs on NK cells, which then depend-
ing on the receptor activate or inhibit the NK cell response
(Parham 2005).
Studies comparing MHC diversity among chimpanzees
sampled at a subspecies or local scale have revealed interest-
ing differences in frequencies of KIR epitopes. For example,
although a comparison between a set of captive western and a
set of wild-born central chimpanzees resident in an African
sanctuary found no differences in nucleotide diversity for the
three MHC class I genes A, B and C, the set of western
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chimpanzees had higher frequencies of MHC-B molecules
carrying the Bw4 KIR epitope and of MHC-C molecules car-
rying the C1 (MHC-C-C1) KIR epitope (Maibach et al. 2017;
Wroblewski et al. 2019). In addition, another set of captive
western chimpanzees had higher frequencies of MHC-B mol-
ecules carrying the Bw4 and the C1 (MHC-B-C1) KIR epi-
tope as compared to the KIR epitopes found on MHC-B mol-
ecules of wild eastern chimpanzees from Gombe National
Park (Wroblewski et al. 2015). The lower frequencies of
MHC molecules with KIR epitopes in central and eastern
chimpanzees were suggested to be the result of selection dif-
ferences among the different subspecies (Wroblewski et al.
2015; Wroblewski et al. 2019). Hence, these findings empha-
size the need for additional studies comparing MHC between
communities, where variation in local selection caused by
pathogens may occur.
Here we compare the MHC-B exon two variation using
samples of western and eastern chimpanzees from two differ-
ent National Parks inWest and East Africa. Chimpanzee com-
munities in both the Taï National Park (Côte d’Ivoire) and
Kibale National Park (Uganda) are known to have experi-
enced several epidemics of respiratory viruses (Emery
Thompson et al. 2018; Hoffmann et al. 2017; Köndgen et al.
2008; Negrey et al. 2019; Scully et al. 2018). In addition,
western chimpanzees from the Taï National Park were also
confronted with outbreaks of Ebola (Formenty et al. 1999;
Leendertz et al. 2017). A comparison of different wild chim-
panzee populations suggested that the Taï chimpanzee popu-
lation might exhibit lower survival rates relative to chimpan-
zees from elsewhere, including Kibale National Park (Hill
et al. 2001; Muller and Wrangham 2014; Wood et al. 2017),
leading to the possibility of differential selection on MHC
diversity.
In this study, we characterizeMHC-B exon two diversity in
geographically localized samples of western and eastern chim-
panzees, aiming to confirm and extend previous findings on
the distribution of MHC variation in wild chimpanzees. Using
DNAs derived from either fecal or necropsy samples, we first
compare levels of exon two nucleotide and amino acid diver-
sity of our two sets of samples. Next, we investigate their
frequencies of the Bw4 and C1 (MHC-B-C1) KIR epitopes.
To put our results into perspective, we include comparisons
with published data from different populations of both wild
and captive western, central, and eastern chimpanzees.
Methods
Samples
We analyzed 28 and 50 individuals representing P. t. verus
(western chimpanzees) and P. t. schweinfurthii (eastern chim-
panzees), respectively (Tables 1 and 2). As part of a project on
determining causes of death in wild chimpanzees (Hoffmann
et al. 2017; Leendertz et al. 2004), necropsy samples are rou-
tinely collected at the Taï National Park, Côte d’Ivoire and
analyzed at the Robert Koch Institute, Germany (https://
www.leendertz-lab.org/). Aliquots of those DNA samples
were used in this study to analyze the western chimpanzee
MHC-B exon two diversity. The 28 western chimpanzees
from this study were members of four habituated and one
semi-habituated neighboring chimpanzee groups (Table 1)
(Herbinger et al. 2001; Kouakou et al. 2011; Wittig 2018).
Our sampling of western chimpanzees contains five individ-
uals known to be related (onemother with three offspring with
different fathers and two individuals with the same father)
(Table 1).
For the eastern chimpanzees in our study, we used part of a
collection of fecal samples that were noninvasively collected
in the Kibale National Park, Uganda between 2011 and 2016
as part of long-term study of the habituatedNgogo community
and monitoring of the unhabituated neighboring communities
(Granjon et al. 2016; Langergraber et al. 2009; Langergraber
et al. 2011; Langergraber et al. 2007; Langergraber et al.
2013). Details on sample preparation are described in White
et al. (2019). Briefly, fecal samples were extracted and DNAs
were genotyped using a panel of microsatellites to establish
individual identities. For quality assessment, the genotyped
samples (> 1700) were further analyzed by a qPCR assay
and with the fragment analyzer system (Large Fragment
Standard Sensitivity Kit; Advanced Analytical) to calculate
the percentage of chimpanzee-derived DNA in those fecal
extracts relative to DNA derived from other sources such as
bacteria and fungi (see White et al. 2019). Based on those
screening results, we estimated an “evaluation score,” which
incorporates the DNA concentration given by qPCR, the
DNA concentration given by the fragment analyzer, the aver-
age length of DNAmolecules given by the fragment analyzer,
and the percentage of chimpanzee-derived DNA into account.
We calculated for each of these four measures the average
value of all samples tested in White et al. (2019) (> 1700)
and divided the individual values of these four measures
(e.g., DNA concentration by qPCR) of each sample by the
average values. This gave a relative value indicating the sam-
ple’s performance for eachmeasure, with relative values larger
than one indicating that the sample had a higher value than the
average of all samples for this particular measure. We next
calculated for each sample the product of relative values of
each of the four measures and sorted all samples based on this
calculated product. Samples with the highest “evaluation
scores” were considered the most promising extracts to use
in this study. We excluded DNA extracts which were older
than 2015 from the dataset, as preliminary results indicated a
reduced PCR performance with such extracts. This reduced
the initial dataset from more than 1700 samples to 831 sam-
ples. From the remaining dataset, we selected 50 samples with
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the highest evaluation scores for attempting MHC class I B
exon two amplification and sequencing. We chose a larger
number of eastern chimpanzee samples compared to our set
of western chimpanzees because we expected a lower PCR
success rate using the fecal extracts than the necropsy sam-
ples. We analyzed the usefulness of the evaluation score by
checking for correlations of the evaluation score or one of the
four individual measurements with poor fecal DNA sample
performance in the PCRs. Although microsatellite analysis
confirmed that the samples used represent different individ-
uals, we did not know whether some of our samples were
closely related. However, we expect the frequency of close
relatives to be low given the large geographical area sampled
and the low proportion of close relatives in wild animal pop-
ulations (Csillery et al. 2006).
PCR amplification and library preparation
We conducted PCRs targeting the complete exon two of the
chimpanzee MHC class I B gene (Supplementary Table 1).
Products had an estimated length of about 464 base pairs.
PCRs were set up in a total volume of 25 μl containing 1×
Buffer B (Kapa Biosystems, Wilmington, MA, USA),
0.2 mM dNTPs, 0.25 μM of each primer, 0.5 units of
Kapa2G Robust HotStart DNA polymerase (Kapa
Biosystems, Wilmington, MA, USA), and 2 μl of DNA ex-
tract. We performed a two-step PCR protocol with an initial
denaturation of 5 min at 95 °C, followed by 40 cycles of 15 s
at 95 °C and 20 s at 72 °C, finished by a final elongation at 72
°C for 5 min. PCR products were checked by gel electropho-
resis on a 2.5% Agarose TAE gel. If amplification was suc-
cessful, PCR products were cleaned from PCR reagents and
primer dimers with AGENCOURT AMPure XP PCR purifi-
cation (Beckman Coulter Life Sciences, Indianapolis, IN,
USA) following suppliers’ instructions, with a ratio of mag-
netic beads to DNA of 0.8. Cleaned PCR products were the
template for a second PCR used to prepare the samples for
sequencing by adding two distinctive indices and Illumina P5
and P7 adapters to each sample. In addition to the DNA se-
quence necessary to amplify exon two, our primer sequences
for the first PCR contained at the 5′ ends adapter sequences
which were the target for the primer annealing in the second
PCR (Supplementary Table 1). This second PCR (indexing
PCR) had a total volume of 25 μl with 1× Phusion Hot Start
II High-Fidelity PCR Master Mix (Thermo Fisher, Waltham,
MA, USA), 0.5μMof each primer P5-iPCR and P7-iPCR and
Table 1 Necropsy samples from
the Taï National Park representing
our set of western chimpanzees.
Allele 1 and allele 2 show the
MHC-B exon two sequences of
the particular individuals. The
two KIR epitopes Bw4 and C1
(MHC-B-C1) at the particular
MHC-B molecules are indicated.
The absence of a KIR epitopes is
shown by dashes (–). Unk.
indicates unknown cause of
death. Superscript numbers show
relatedness of individuals:
1Ophelia with her three children,
2Ophelia and Shogun have the
same father





Dorry North Unk. October 21, 2001 B-12 B-25 C1/C1
Unknown I North East Intergroup
encounter
July 21, 2015 B-09 B-12 C1/C1
Kady Middle Unk. December 11, 2001 B-08 B-09 –/C1
Noah Middle Unk. February 13, 2002 B-11 B-11 Bw4/Bw4
Leo Middle Anthrax February 14, 2002 B-08 B-10 –/Bw4
Candy East Pneumonia February 07, 2006 B-21 B-12 Bw4/C1
Vasco East Pneumonia February 09, 2006 B-08 B-08 –/–
Porthos East Anthrax April 07, 2008 B-10 B-11 Bw4/Bw4
Dartagnon East Anthrax April 19, 2009 B-09 B-26 C1/C1
Iome East Anthrax April 22, 2009 B-09 B-11 C1/Bw4
Ouganda East Anthrax August 22, 2011 B-08 B-08 –/–
Mila East Unk. January 15, 2012 B-10 B-12 Bw4/C1
Ehra East Anthrax January 08, 2014 B-09 B-28 C1/C1
Tita South Anthrax September 26, 2000 B-08 B-12 –/C1
Olduvai1 South Anthrax June 13, 2002 B-13 B-11 Bw4/Bw4
Orest1 South Pneumonia March 10, 2004 B-11 B-13 Bw4/Bw4
Ophelia1,2 South Pneumonia March 10, 2004 B-14 B-11 Bw4/Bw4
Virunga South Leopard/pneumonia March 19, 2004 B-09 B-08 C1/–
Ishas Baby South Unk. February 10, 2006 B-09 B-11 C1/Bw4
Olivia1 South Leopard December 07, 2009 B-11 B-11 Bw4/Bw4
Louise South Pneumonia December 07, 2009 B-11 B-12 Bw4/C1
Atra South Pneumonia December 08, 2009 B-11 B-13 Bw4/Bw4
Wapi South Pneumonia December 17, 2009 B-27 B-08 C1/–
Shogun2 South Anthrax March 07, 2016 B-15 B-16 Bw4/–
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0.6μl of cleaned PCR product from the first PCR. The cycling
protocol for the indexing PCR started with an initial denatur-
ation of 30 s at 98 °C, followed by 20 cycles of 10 s at 98 °C,
20 s at 58 °C, and 20 s at 72 °C, finished by a final elongation
for 5 min at 72 °C. PCR products of this second PCR were
again checked by gel electrophoresis on a 2.5% TAE agarose
gel and cleaned by AGENCOURT AMPure XP PCR purifi-
cation with a ratio of beads to DNA of 0.6. We analyzed each
individual in two replicates, i.e., this entire process was done
for each individual in two independent reactions. If one of the
two replicates per individual failed or showed rather weak
bands on the gel electrophoresis during this process, we re-
peated the PCR reactions for this particular individual a third
time. We analyzed all products using the Fragment Analyzer
system (Large Fragment Standard Sensitivity Kit; Advanced
Analytical) to estimate the DNA concentration of each library
(sample). We observed that not every PCR replicate had the
necessary DNA concentration (~ 300 pg) for sequencing, al-
though some replicates which appeared to have insufficient
DNA concentration as estimated by the gel electrophoresis
showed a suitable DNA concentration on the fragment ana-
lyzer. Consequently, we had no PCR replicate for three west-
ern and two eastern chimpanzees; only one of the two desired
replicates for 14 other individuals (five western and nine east-
ern chimpanzees); and for seven eastern chimpanzees, three
replicates available for sequencing. Based on the DNA con-
centrations estimated using the fragment analyzer, we mixed
all libraries (samples) equimolar into two different pools (n =
15 and n = 124, respectively), with a final molarity of 10 nM
and 5.04 nM, respectively.
Sequencing and sequence processing
We sequenced both libraries on one lane on an IlluminaMiSeq
platform (Illumina, San Diego, CA, USA) using 250 base pair
(bp) paired-end runs with two 7-bp indices. To increase se-
quence complexity, an indexed Phi X 174 library was added
prior to sequencing. In total, we sequenced MHC-B PCR
products for 25 western and 48 eastern chimpanzees. Bases
were called using the standard Illumina base caller Bustard.
We used leeHom to merge overlapping mate pairs and trim
adapter sequences (Renaud et al. 2014). Demultiplexing of
reads, i.e., the assignment of reads to a sample based on their
indices, was done by deML (Renaud et al. 2015). We further
processed the data by removing reads with an expected num-
ber of mismatches greater than one per 100 bases and reads
with a length shorter than 250 base pairs using SAMtools
1.3.1 (Li et al. 2009). From the filtered reads, we then extract-
ed the MHC B exon two sequences from each sample with
jMHC (Stuglik et al. 2011), using the primer sequences from
our first PCR. We filtered the output from jMHC by the min-
imum read length of 100 base pairs and a minimum variant
count of 50, i.e., a certain sequence must have had at least 50
reads to be considered. We then checked the output from
jMHC for every sample in BioEdit 7.2.5 (Hall 1999) and
extracted the alleles for each sample. We considered the se-
quences with the highest number of reads as the true alleles of
an individual, and all other sequences with lower number of
Table 2 Fecal samples from the Kibale National Park representing our
set of eastern chimpanzees. Allele 1 and allele 2 show the MHC-B exon
two sequences of the particular individuals. KIR epitopes at the particular
MHC-Bmolecules are indicated. The absence of a KIR epitopes is shown
by dashes (–)
Extract ID Date of sampling Allele 1 Allele 2 KIR
N322-4 NS257 November 18, 2014 B-03 B-07 Bw4/Bw4
N322-5 NS299 December 10, 2014 B-05 B-06 –/–
N322-6 NS300 January 09, 2015 B-07 B-07 Bw4/Bw4
N322-7 NS222 January 09, 2015 B-04 B-07 Bw4/Bw4
N323-6 ES19 April 18, 2015 B-06 B-06 –/–
N319-2 NS284 July 27, 2014 B-18 B-07 –/Bw4
N319-4 NS286 July 27, 2014 B-03 B-04 Bw4/Bw4
N319-5 NS281 July 27, 2014 B-05 B-06 –/–
N320-6 NS292 October 06, 2014 B-05 B-07 –/Bw4
N320-8 NS294 October 06, 2014 B-06 B-07 –/Bw4
N412-7 B37 January 11, 2015 B-05 B-18 –/–
N403-9 B41 June 24, 2015 B-07 B-06 Bw4/–
N408-4 KT4 September 18, 2015 B-05 B-17 –/Bw4
N410-5 B59 October 18, 2015 B-06 B-06 –/–
N411-1 B80 October 18, 2015 B-07 B-17 Bw4/Bw4
N412-10 B63 November 16, 2015 B-07 B-07 Bw4/Bw4
N413-1 NS12 November 17, 2015 B-06 B-07 –/Bw4
N414-6 B66 December 22, 2015 B-04 B-19 Bw4/–
N415-10 B38 January 15, 2016 B-07 B-06 Bw4/–
N415-9 B40 January 15, 2016 B-06 B-07 –/Bw4
N416-1 B17 January 16, 2016 B-06 B-07 –/Bw4
N444-10 B31 April 04, 2016 B-07 B-04 Bw4/Bw4
N444-6 B5 April 04, 2016 B-07 B-07 Bw4/Bw4
N444-7 KT7 April 04, 2016 B-07 B-06 Bw4/–
N445-2 B61 April 04, 2016 B-06 B-07 –/Bw4
N445-4 NS264 April 04, 2016 B-06 B-04 –/Bw4
N443-7 B103 May 04, 2016 B-04 B-07 Bw4/Bw4
N446-3 B108 May 04, 2016 B-06 B-07 –/Bw4
N446-5 B54 May 19, 2016 B-06 B-06 –/–
N449-7 B114 July 17, 2016 B-05 B-04 –/Bw4
N326-5 NS307 July 25, 2014 B-06 B-04 –/Bw4
N350-6 NS184 May 01, 2015 B-19 B-07 –/Bw4
N387-1 M93 October 16, 2014 B-06 B-06 –/–
N390-10 NS278 November 04, 2014 B-06 B-07 –/Bw4
N391-9 M58 November 18, 2014 B-06 B-04 –/Bw4
N396-4 M31 January 17, 2015 B-07 B-03 Bw4/Bw4
N426-2 M4 September 28, 2015 B-05 B-03 –/Bw4
N378-6 NS365 May 02, 2015 B-06 B-03 –/Bw4
N451-18 TA1 October 20, 2015 B-20 B-18 Bw4/–
N328-9 NS311 August 25, 2014 B-06 B-03 –/Bw4
N344-6 NS332 April 18, 2015 B-04 B-03 Bw4/Bw4
N374-5 NS362 June 21, 2015 B-06 B-07 –/Bw4
N433-8 NS250 March 21, 2016 B-03 B-07 Bw4/Bw4
N331-4 NS173 October 06, 2014 B-07 B-04 Bw4/Bw4
N331-6 NS149 October 10, 2014 B-06 B-06 –/–
N349-3 NS340 November 24, 2014 B-23 B-06 Bw4/–
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reads were removed. These had a few differences to the ac-
cepted sequence, as one would expect if these low frequency
sequences arose due to polymerase misincorporation during
PCR or incorrect base calling during sequencing. In the ma-
jority of cases, the difference in the number of reads between
the considered alleles (one to several thousand reads) and
sequences with errors (a few hundred reads) was relatively
large. However, in five instances, one allele had a high number
of reads, whereas the second allele had only a few reads which
were in the range of the sequences with errors. Despite that
low coverage, the second allele was considered as “real” be-
cause it showed several differences to the first, well-supported
allele (not only a few polymerase misincorporations) and was
also found in the replicate of the individual and in other indi-
viduals as well. We excluded one western and two eastern
chimpanzee individuals from the dataset, because we had no
second PCR replicate for these individuals and the samples
showed ambiguous sequencing results, i.e., the read number
of amplicons was low and several possible sequences were
present for these particular samples. This reduced our sample
size to 24 western and 46 eastern chimpanzees, respectively.
After all filtering steps, we obtained for those individuals on
average 2011 (range 93–15,061) reads per amplicon. Finally,
we compared all MHC-B exon two sequences among the dif-
ferent individuals and, for differentiation, we designated them
numerically. It is important to note that this numerical desig-
nation is not identical to the official designation recommended
by the IPD-MHC, which is based on full-length MHC-B al-
leles (Maccari et al. 2017). Because MHC-B exon two se-
quences may represent several different full length MHC-B
alleles, we wanted to avoid confusion and preferred a simple
numerical designation rather using the official designated full
length MHC-B allele names.
Data analysis and statistic
We calculated the nucleotide diversity (∏) of the exon two
sequences with the package pegas 0.9 (Paradis 2010) in R (R
Core Team 2015). For statistical analysis of differences in
nucleotide diversity of the exon two sequences between west-
ern and eastern chimpanzees, we conducted a permutation test
with 10,000 permutations (Adams and Anthony 1996). We
pooled all individuals and resampled for each permutation
individuals independent from their taxon origin into two
groups of the same size as the original two groups of western
and eastern chimpanzees (24 and 46, respectively). In each
permutation, we calculated the absolute difference in nucleo-
tide diversity between the two groups and compared this with
the observed absolute difference in nucleotide diversity of the
two groups of western and eastern chimpanzees. We calculat-
ed the p value as the proportion of absolute differences in
nucleotide diversity of every permutation being larger or equal
than the observed absolute difference in nucleotide diversity
of the two groups of western and eastern chimpanzees.
However, the difference in samples size numbers between
western and eastern chimpanzees could have an influence on
the results of the permutation test (Huang et al. 2006). We
therefore conducted an additional test, where we resampled
from both chimpanzee sets 20 individuals to equalize the sam-
ple size number for the two groups. We resampled the chim-
panzee subsets one million times and calculated each time the
nucleotide diversity. In addition, we compared the exon two
nucleotide diversity of our western and eastern chimpanzee
sets with the exon two nucleotide diversity of western, central,
and eastern chimpanzee sets described in other studies. We
accounted for the different number of sampled individuals in
those studies by resampling for each chimpanzee set 20 indi-
viduals, which was the minimum sample size number in two
of those studies from the literature. We resampled 20 individ-
uals of each particular chimpanzee set one million times (in-
cluding also our western and eastern chimpanzee sets) and
calculated each time the nucleotide diversity.
For the analysis of the diversity of the exon two amino acid
sequences, we used the protein variability server which calcu-
lates the Shannon entropy, the Simpson diversity index, and
the Wu-Kabat variability coefficient (Garcia-Boronat et al.
2008). Other statistical tests are indicated at the corresponding
section in the results. For the Fisher exact tests, we used the R
package rcompanion 1.3.2 (Mangiafico 2015). We accounted
for multiple testing by using the Bonferroni correction which
relies on the adjustment of the significant threshold by divid-
ing the initial significant threshold of 0.05 by the number of
tests conducted on the same dataset. The adjusted significant
thresholds are presented with the statistical tests in the results.
Results
We started our project with samples from 28 and 50 different
western and eastern chimpanzees and were able to produce
unambiguous sequencing results for 24 and 46 individuals,
respectively. Hence, only four necropsy (western chimpan-
zees) and four fecal (eastern chimpanzees) samples failed.
Specifically, the PCR success rate was 80% (45 of 56) using
DNAs derived from necropsy samples and 77% (94 of 112)
for DNAs derived from feces.
To guide future research using DNA from feces, we
checked if one of our four screening measures (DNA concen-
trations given by qPCR and fragment analyzer, the average
length of DNAmolecules, and the percentage of chimpanzee-
derived DNA) or the composite evaluation score correlated
with poor fecal DNA sample performance. We found a weak
negative correlation between our evaluation score and the fail-
ure of a DNA extract to amplify in one of the PCR replicates,
indicating that a low evaluation score slightly increased the
probability that a sample failed in one of the PCR replicates
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(Pearson’s product-moment correlation, r = − 0.316, t = −
2.308, df = 48, p value = 0.025). None of the four individual
screening measurements showed a correlation with PCR suc-
cess rate (data not shown).
In total, we found 14 and 10 different nucleotide sequences
from the 24 western and 46 eastern chimpanzees, respectively
(Tables 1 and 2; GenBank accession numbers: MN213635–
MN213661). Two of the 14 western chimpanzee sequences
(B-11 and B-21) had an identical exon two DNA sequence but
one nucleotide substitution in the intron one region (Table 3).
We therefore found 13MHC-B exon two DNA sequences for
western and 10 for the eastern subspecies. The number of
differences distinguishing the exon two sequences within
these two sets ranged from 1 to 33 differences, with an average
number of differences of 19.4 for western and 18.2 for eastern
chimpanzees. Each of the 13 and 10 different nucleotide se-
quences coded for a unique amino acid sequence. Comparison
with exon two sequences from the literature indicated that
three of our 13 western chimpanzee sequences have not been
previously described, while all 10 eastern chimpanzee exon
two sequences were previously reported (Table 3). None of
the exon two sequences were shared between the two subspe-
cies (Fig. 1).
We compared the allele frequencies of the exon two se-
quences between our samples of the two subspecies. In each
of our sampled populations, the allele frequencies were not
evenly distributed. We found one (B-11) or two (B-06 and
B-07) high-frequency alleles, respectively, as well as alleles
with intermediate or low frequencies (Fig. 1). Interestingly, we
found fewer MHC-B exon two sequences (10) in our set of
eastern chimpanzees than in our set of western chimpanzees
(13), despite the sample size of eastern chimpanzees being
nearly twice that of western chimpanzees. This suggests rela-
tively lower diversity in our set of eastern chimpanzees. To
further analyze this observation, we compared the nucleotide
diversity of the exon two sequences between western and
eastern chimpanzees (Fig. 2). We found a significantly higher
nucleotide diversity in our set of western chimpanzees (per-
mutation test, p = 0.0058). However, the results of the permu-
tation test could be biased by the differing number of sampled
chimpanzees (Huang et al. 2006). We accounted for this by
resampling 20 individuals of both sets of eastern and western
chimpanzees to equate the sample size number (Fig. 3). After
one million repetitions, the nucleotide diversity of the
resampled eastern chimpanzee subsets was still lower than
the nucleotide diversity of the resampled western chimpanzee
subsets, supporting the previous findings of the permutation
test.
We next compared the exon two nucleotide diversity of our
western and eastern chimpanzee samples with the exon two
Table 3 Comparison of exon two
sequences found in this study
with complete MHC-B sequences
from the literature. New alleles
are indicated in italics. #Allele B-
11 and B-21 had an identical exon
two sequence but one nucleotide
substitution in the intron one
region and are therefore listed
together in this table
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nucleotide diversity of two sets of captive western chimpan-
zees (formerly housed at BPRC, Netherlands and Yerkes,
USA), one set of captive central chimpanzees (Tchimpounga
Sanctuary, Republic of Congo) and one set of wild eastern
chimpanzees, representing three different communities
(Gombe National Park, Tanzania) (Adams et al. 2000; de






























Fig. 1 The frequencies of the
differentMHC-BDNA sequences
found in our set of western (24
individuals) and eastern
chimpanzees (46 individuals)
from the Taï National Park and
the Kibale National Park,
respectively. KIR epitopes present
at the particular MHC-B
sequences are indicated in
brackets. MHC-B sequences have
































western chimpanzees eastern chimpanzees
(24) (46)
*
Fig. 2 The DNA nucleotide
diversity of theMHC-B exon two
sequences of our sets of western
(golden) and eastern chimpanzees
(purple). The star above the bars
indicates a significant difference
between the two sets of sequences
(permutation test, p = 0.0058).
Sample size is indicated below the
bars
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Groot et al. 2010; Maibach et al. 2017; Wroblewski et al.
2015). We resampled 20 individuals from the different chim-
panzee sets to account for differences in sample size number
among the particular sets. The 20 central chimpanzees had the
highest exon two nucleotide diversity. Interestingly, the west-
ern chimpanzees from the BPRC and Yerkes showed similar
exon two nucleotide diversity compared to our set of western
chimpanzees (Taï) but were slightly lower compared to the
single set of central chimpanzees (Fig. 4). Although including
representatives of three communities, the set of Gombe chim-
panzees as well as our set of Kibale chimpanzees had the
lowest exon two diversity estimates (Fig. 4).
We further investigated if the difference in DNA sequence
diversity between our sets of western and eastern chimpanzees
was also present on the amino acid level. We compared the
Shannon entropy, the Simpson diversity index, and the Wu-
Kabat variability coefficient between our 24 western and 46
eastern chimpanzees (Fig. 5). The three different diversity
measurements indicated the same results for the individual
amino acid positions except for positions 60, 63, and 70. At
position 60, the Shannon entropy and the Simpson diversity
index indicated a slightly lower value for our set of western
chimpanzees; however, the Wu-Kabat variability coefficient
indicated no difference between the two sets of chimpanzees.
Furthermore, at position 63, the Shannon entropy and the
Simpson diversity index indicated a higher value for our set
of western chimpanzees, whereas the Wu-Kabat variability
coefficient indicated a higher diversity for our set of eastern
chimpanzees. In addition, at position 70, the Shannon entropy
indicated no difference between our sets of western and east-
ern chimpanzees, in contrast to a slightly higher diversity for
western chimpanzees indicated by the Simpsons diversity in-
dex or a higher diversity for eastern chimpanzees indicated by
the Wu-Kabat variability coefficient. Furthermore, it is impor-
tant to note that the Shannon entropy and the Simpsons diver-
sity index showed higher values for most of the amino acid
positions compared to the Wu-Kabat variability coefficient.
Nevertheless, all three diversity measurements showed the
same polymorphic amino acid positions for the two sets of
chimpanzees, including all positions important for the peptide
binding and the KIR interactions (Fig. 5). Similar analyses
performed on the data from BPRC, Yerkes, Tchimpounga,
and Gombe emphasized the same polymorphic positions (data
not shown).
In total, our two sets of sequences contain 32 polymorphic
amino acid positions. We tested for a difference in amino acid
diversity between our sets of western and eastern chimpanzees
by comparing the number of polymorphic amino acid posi-
tions and the diversity values at these positions. Although our
set of western chimpanzees had slightly more polymorphic
amino acid positions than our set of eastern chimpanzees (31
vs. 25), our set of western chimpanzees did not have signifi-
cantly higher diversity at the polymorphic positions than did
our set of eastern chimpanzees after Bonferroni correction
(Bonferroni corrected significant threshold p ≤ 0.0167;
Shannon entropy: mean 25.728 vs. 20.953, Wilcoxon
signed-rank test, V = 374, p value = 0.041; Simpsons diversity
index: mean 11.485 vs. 9.715, Wilcoxon signed-rank test, V =
368, p value = 0.053; Wu-Kabat variability coefficient:
172.099 vs. 156.905, Wilcoxon signed-rank test, V = 347, p
value = 0.123).
We next checked for KIR epitopes in the different
MHC-B sequences of our two sets of chimpanzees. We
found that for the two possible Bw4 and C1 (MHC-B-C1)
KIR epitopes at the chimpanzee MHC-B locus, only our
set of western chimpanzee sequences contained both the
Bw4 and C1 epitopes, whereas our set of eastern chim-
panzee sequences had only the Bw4 epitope (Tables 1 and
2; Fig. 6). The two epitopes are determined either by an
arginine at position 83 (Bw4) or a valine and an aspara-
gine at positions 76 and 80 (C1), respectively (Parham
and Moffett 2013). None of the eastern chimpanzee se-
quences had a valine at position 76, explaining the ab-
sence of the MHC-B-C1 epitope in this set of sequences
(Fig. 6). Within our set of western chimpanzees, 22 out of
24 individuals (92%) had MHC-B sequences with KIR
epitopes with relatively similar frequencies between the
Bw4 and the MHC-B-C1 epitope (Table 4a). Of the 46
eastern chimpanzees in our dataset, 38 individuals (83%)
had MHC-B sequences with the Bw4 epitope. The num-































































Fig. 3 The MHC-B exon two nucleotide diversity of our sets of western
(golden) and eastern chimpanzees (purple) based on one million
resamplings of 20 individuals to match sample size numbers between
the two sets of chimpanzees. The shape of the particular plots indicates
the distribution of these calculated nucleotide diversities. The number of
individuals of the original groups is indicated in brackets
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different between our two sets of MHC-B sequences (92%
vs. 83%, Fisher’s exact test, p = 0.8546).
To put the results in a broader context, we next compared
the frequencies of the Bw4 and the MHC-B-C1 epitopes in
our samples as well as samples from other studies (Table 4;
Supplementary Table 2), as previously done by Wroblewski
et al. (2019), and including additional data from de Groot et al.
(2010) and Wroblewski et al. (2015). With regard to Bw4, we
found that the frequencies of chimpanzees with this epitope
differed significantly among the different sets of chimpanzees
(Fisher’s exact test of independence, p = 0.0005). However,
subsequent pairwise analysis using a post-hoc test revealed
that the frequencies of chimpanzees with the Bw4 epitope








































































































Fig. 5 Plot of the three amino acid diversity measurements Shannon
entropy, Simpson diversity index and Wu-Kabat variability coefficient
for amino acid positions of the MHC-B exon two sequences for our two
set of western (golden) and eastern (purple) chimpanzees. The number of
individuals for each set as well as the positions important for the peptide























































































































Fig. 4 The MHC-B exon two nucleotide diversity comparison of our set
of samples with different sets of western (golden), central (blue), and
eastern chimpanzees (purple) from the literature. Sample locations and
the number of individuals of each particular chimpanzee set are indicated
below the plots. We resampled 20 individuals one million times from
each set and calculated the nucleotide diversities. The shape of the
particular plots indicates the distribution of these calculated nucleotide
diversities
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comparison of Gombe and Kibale, indicating a higher fre-
quency of the Bw4 epitope in Kibale (post-hoc test Fisher’s
exact test, p < 0.0001) (Tables 4a and 5). As with the Bw4
epitope, the frequency of individuals with the MHC-B-C1
epitope also differed among the different chimpanzee sets
(Fisher ’s exact test of independence, p = 0.0005).
Interestingly, each non-eastern chimpanzee set (i.e., Taï,
Yerkes, BPRC and Tchimpounga) had significantly higher
frequencies of individuals carrying the MHC-B-C1 epitope
compared to the frequency of individuals with the MHC-B-
C1 epitope in Gombe and Kibale (both eastern chimpanzee
sets) (post-hoc test Fisher’s exact test, p ≤ 0.0019; Table 5). In
addition, we grouped all chimpanzees by subspecies and com-
pared the frequencies of individuals with the Bw4 and MHC-
B-C1 epitope, respectively (Table 4b). This included also
some individuals (in total 14) from three different subspecies
presented in Wroblewski et al. (2019) which were not includ-
ed in the previous comparison because the grouping of so few
individuals as several independent sets of chimpanzees would
have been confusing (Supplementary Table 2). When compar-
ing the frequencies of chimpanzees with the Bw4 epitope
among the three subspecies, we found no significant
difference for the Bw4 epitope (Table 4b; Fisher’s exact test
of independence, p = 0.0648). However, as expected, based on
the results for the MHC-B-C1 epitope from the previous com-
parison, we found higher frequencies of individuals with the
MHC-B-C1 epitope in western and central chimpanzees, com-
pared to eastern chimpanzees (Table 4b; Fisher’s exact test of
independence and post-hoc Fisher’s exact tests, p < 0.0001),
while there was no difference in MHC-B-C1 epitope frequen-
cy between western and central chimpanzees (post-hoc
Fisher’s exact tests, p = 0.8156).
Discussion
In this study, we analyzed 24 western (P. t. verus) and 46
eastern (P. t. schweinfurthii) wild chimpanzee MHC-B exon
two sequences sampled using necropsy and fecal samples,
respectively, and compared the results with those previously
reported from other samples of chimpanzees. We demonstrat-
ed that, although it was challenging, we could generateMHC-
B exon two sequences using these sample types. Although one
might expect that tissue samples derived from a necropsy
Position 4 6 7 9 11 12 24 32 35 41 42 45 46 49 52 60 63 65 66 67 69 70 71 74 76 77 79 80 81 82 83 90
Consensus S R Y Y A V T Q R A S K E A I W E Q I S T N A Y E N R N A L R A
B-10 . . . D . . . . . . . M . . . . . R N V A S . D . . . I . . . . Bw4
B-11/B-21 . . . . S . . . . . . M . . . . . R N M A S . D . . . I . . . . Bw4
B-13 . K . . . . . . W . . . . T . . . . . . . . . D . . . T L . . . Bw4
B-14 . . . . . . . . . . . M . . . . . R N V A S . D . . . I . . . . Bw4
B-15 F . . . . M A . . . . M A . . . . R N M A S . . . . . I . . . . Bw4
B-09 . . . . S . S . . . . E . . M . N . . Y A Q . D V S G . L R G . C1
B-12 . . D . . M A . . . I M . . . . . . . . . . . . V G . . L R G . C1
B-25 . . . . . M A . . . I M . . . . . . . . . . . . V G . . L R G . C1
B-26 . K . . . . . . W . . . . T . . . . . . . . . D V S . . L . . . C1
B-27 . K . . S . S . . . . V . . M C . . . F . . T D V S G . L G G . C1
B-28 . K . . . . . . W . . . . T . . . . . . . . . . V G . . L R G . C1
B-08 . K . . . . S . W . . E . . . . . . . . . . . . . S . . L R G . -
B-16 . . . H . M . L . T . . . . . . . . . . . . T . . S . . L R G . -
B-03 . K . . . . . . W . . . . T . . . . . . . . . . . . . I . . . . Bw4
B-04 . K . L S . . . . . . M . . . . . R N V A F . . . . . I . . . D Bw4
B-07 . K . L S . . . . . . M . . . . . R N V A S . . . . . I . . . D Bw4
B-17 . K . . . . . . W . . . . T . . . . . . . . T . . . . I . . . . Bw4
B-20 . . . . S . S . . . . E . . M . N . . Y A Q . D . . . I . . . . Bw4
B-23 . K . . . . S . W . . E . . . . . . . . . . T . . . . I . . . . Bw4
B-05 . K . . . . S . . . . E . . . . . . . . . . . D . S . . L R G . -
B-06 . K . . . . . . W . . . . T . . . . . . . . T . . S . . L R G . -
B-18 . K . . S . S . . . . V . . M C . . . F . . T D G S G . L R G . -
B-19 . K . F S . . . . . . V . . . . Q . . . . . . D G S G . L R G . -
KIR 
epitope
Fig. 6 The amino acids of all 32 polymorphic positions of the MHC-B
exon two molecules for our set of western (upper panel) and eastern
(lower panel) chimpanzees, respectively. Within each panel, sequences
are grouped byKIR epitopes and sequence designation. Similarities to the
consensus sequence are indicated by dots. KIR epitopes for each
sequence are indicated and defined by positions 69, 76, 79, 80, and 83
(yellow shading). Positions important for the peptide binding of the
MHC-B molecules are indicated by blue shading. Position 80 is
involved in the peptide binding and the interaction with KIRs
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would provide good quality DNA, the samples were collected
in field conditions at varying times after death, thus explaining
the 80% PCR success rate from western chimpanzees.
Similarly, although the amplicon has a relatively modest
length of < 500 bp, this can be challenging to amplify from
the low-quality, low concentration DNA typically obtained
from feces, thus explaining the 77% PCR success rate when
using fecal DNAs from eastern chimpanzees. Indeed, because
the DNA is highly degraded in fecal samples and potentially
contains DNA from many other organisms like bacteria, we
expected a much higher failure rate than we observed
(Taberlet et al. 1999; White et al. 2019). However, this rela-
tively low failure rate reflects the intensive assessment of fecal
samples quality parameters (evaluation score) prior to PCR
and sequencing and our selection of 50 samples with the
highest evaluation scores (White et al. 2019). Although we
found only a weak correlation between the evaluation score
and PCR success rate, this likely reflects range restriction, and
inclusion of samples with lower evaluation scores might fur-
ther validate the idea that the evaluation score predicts the
samples PCR and sequencing success rate.
The presence of 13 and 10 different exon two nucleotide
and amino acid sequences for our western and eastern chim-
panzees, respectively, indicated a higher number of MHC-B
alleles in our set of western chimpanzees. However, it is im-
portant to note that the MHC-B exon two sequences could
represent several different full length MHC-B alleles, and
therefore, the number of full length MHC-B alleles in these
two sets of chimpanzees could differ as compared to the num-
ber of exon two sequences. The unequal distribution of the
exon two frequencies in our two sets of sequences, e.g., one or
two alleles with high frequencies, followed by alleles with
intermediate and low frequencies, are comparable to the dis-
tribution of allele frequencies found in other studied chimpan-
zee and small indigenous human populations (Wroblewski
et al. 2015). Interestingly, our B-06 exon two sequence, which
had the highest frequency in our set of eastern chimpanzees,
had the same exon two sequence as the B*22:04 allele which
had the highest frequency in Gombe eastern chimpanzees
(Wroblewski et al. 2015). In addition, the B-11 and B-08 exon
two sequences which had the highest and the second highest
frequencies in our set of western chimpanzees had identical
exon two sequences compared to the two alleles with the
highest frequencies (B*01:01 and B*05:01) in western chim-
panzees from the BPRC and Yerkes (Adams et al. 2000; de
Groot et al. 2010; Wroblewski et al. 2015). The presence of
the same MHC-B alleles in high frequencies across different
chimpanzee populations implies some importance of these
alleles and might indicate a subspecies-specific pattern of
high-frequencyMHC-B alleles, maybe representing the result
of selection acting on these subspecies.
The higher number of exon two sequences in our set of
western chimpanzees compared to our set of eastern chimpan-
zees hinted at a lowerMHC-B exon two diversity in our set of
eastern chimpanzees. This was supported by the lowerMHC-
B exon two nucleotide diversity in our set of eastern chimpan-
zees compared to our set of western chimpanzees.
Interestingly, the comparison with other chimpanzee sets from
different western, central, and eastern chimpanzee populations
showed a similar pattern of high exon two nucleotide diversity
in western chimpanzees compared to low exon two nucleotide
diversity in eastern chimpanzees. This suggests that the differ-
ences in MHC-B exon two diversity which we found among
individuals of the Taï National Park and the Kibale National
Table 4 Frequencies of
chimpanzees with the two KIR
epitopes Bw4 and C1 (MHC-B-
C1) compared among different
chimpanzee populations/sets (a)
and compared among the three
subspecies (b). The subspecies
comparison includes all
populations/sets presented in this
table and in addition few
chimpanzees (14) which were not
included in the population
comparison because the grouping
of so few individuals as several
independent sets of chimpanzees
would have been confusing. N
represents the number of
individuals
(a)
Subspecies Population N Epitope frequency
Bw4 C1
Western Taï 24 0.58 0.54
Western BPRC1 25 0.80 0.36
Western Yerkes2 20 0.80 0.50
Central Tchimpounga2 20 0.60 0.45
Eastern Kibale 46 0.83 0
Eastern Gombe3 125 0.48 0.10
(b)
Subspecies N Epitope frequency Bw4 Epitope frequency C1
Western 73 0.73 0.47
Central 23 0.57 0.44
Eastern 178 0.57 0.07
1 de Groot et al. (2010)
2Wroblewski et al. (2019)
3Wroblewski et al. (2015)
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Park represent a consistent difference in MHC-B exon two
nucleotide diversity between western and eastern chimpan-
zees. Regarding the amino acid diversity at polymorphic sites
of the MHC-B exon two amino acid sequences, we found no
evidence of higher amino acid diversity in our set of western
chimpanzees, indicating that the difference in nucleotide di-
versity might not cause a difference in functionality between
our set of western and eastern chimpanzees. However, this
assumes that a more or less equal number of amino acids at
the polymorphic sites lead to an equal functionality of the
particular MHC sequences, which might not be true, because
of different physico-chemical properties of the individual ami-
no acids, leading to differing abilities to interact with peptide
sequences (Matsumura et al. 1992). In addition, our compar-
ison includes all polymorphic sites and not only the sites in-
volved in the forming of the α1 domain of the peptide binding
groove (Bjorkman et al. 1987; Saper et al. 1991). In sum,
drawing conclusions on the functional ability of the MHC-B
exon two sequences of our two sets of chimpanzees is rather
difficult and would need additional investigation of theMHC-
B exon three sequences, which encodes for the α2 domain of
the antigen binding site and proper MHC molecule function-
ality analysis like the investigation of the ability of MHC
molecules to bind viral peptides using bioinformatic binding
prediction tools (Hoof et al. 2009; Maibach and Vigilant 2019;
Pro et al. 2014; van Deutekom et al. 2011).
The comparison of the Bw4 and C1 (MHC-B-C1) KIR
epitope frequencies of the MHC-B sequences among the dif-
ferent chimpanzee sample sets revealed interesting findings.
Previous results on the Bw4 epitope hinted at a reduced fre-
quency of this epitope in eastern chimpanzees compared to
western chimpanzees (Wroblewski et al. 2015; Wroblewski
et al. 2019). However, we found in our set of Kibale eastern
chimpanzees a relatively high Bw4 epitope frequency, which
was comparable to the Bw4 frequencies of western and central
chimpanzees and higher relative to the previous studied east-
ern chimpanzees from Gombe (Wroblewski et al. 2015). This
indicates that differences in the frequency of the Bw4 epitope
cannot be attributed solely to differences between chimpanzee
subspecies, but rather suggests that two populations belonging
to the same subspecies may differ substantially in their Bw4
epitope frequencies. In contrast, the MHC-B-C1 epitope fre-
quency showed clear subspecies differences. The complete
absence of this epitope at MHC-B molecules in our Kibale
and other eastern chimpanzee sets (Wroblewski et al. 2019),
as well as the very low frequency in eastern chimpanzees from
Gombe, strongly indicates a reduced MHC-B-C1 epitope fre-
quency in eastern chimpanzees. However, eastern chimpan-
zees still possess a C1 epitope at some MHC-C molecules
(MHC-C-C1), as indicated by a comparison of KIR epitopes
present at MHC-C molecules (Wroblewski et al. 2019). This
indicates that the majority of KIR interactions of MHC-B
molecules with NK-cells in eastern chimpanzees are mostly
restricted to the Bw4 epitope and not to both the Bw4 and C1
epitopes as in other chimpanzee subspecies. Such changes and
refinement of KIR epitope frequencies at certain MHC genes
have been observed throughout the evolution of hominids, as
comprehensively reviewed by Wroblewski et al. (2019). For
example, like eastern chimpanzees, humans possess an ex-
tremely low frequency of the MHC-B-C1 epitope, presented
only by two human MHC-B molecules, which might have
been introduced into modern humans by archaic humans after
complete loss of the MHC-B-C1 epitope (Abi-Rached et al.
2011; Wroblewski et al. 2019). Even further changes have
been observed in the bonobos, close relatives of the chimpan-
zees who lack the C1 epitope on their MHC-C molecules
(Wroblewski et al. 2019). In addition and more importantly,
bonobos lack the specific KIR genes responsible for the inter-
action with C1 epitopes, indicating that even bonobos that
would have the C1 epitope at some MHC-B molecules none-
theless lack the ability to interact with the C1 epitope
(Rajalingam et al. 2001; Wroblewski et al. 2019). These ex-
amples demonstrate that KIR and MHC genes and their inter-
actions constantly changed throughout hominid evolution.
The differences of MHC-B-C1 epitope frequencies among
the different chimpanzee subspecies show that the complex
evolutionary pattern of KIR and MHC genes observed among
different hominid species might also be present at the subspe-
cies level of a single ape species.
The reducedMHC-B exon two nucleotide diversity in east-
ern chimpanzees contrasts with their higher genetic autosomal
diversity, larger effective population size, and less severe
Table 5 Statistical results of Bw4
and C1 (MHC-B-C1) epitope
frequency comparison among
different chimpanzee populations.
The upper right part shows the
p values for the C1 (MHC-B-C1)
epitope. The lower left part shows
the p values for the Bw4 epitope.
Significant values are indicated in
italics. We corrected for multiple
testing using the Bonferroni
correction (adjusted significant
threshold 0.05/15 = 0.0033)
Bw4\C1 BPRC Yerkes Taï Tchimpounga Gombe Kibale
BPRC – 0.3792 0.2563 0.5587 0.0019 < 0.0001
Yerkes 1 – 1 1 0.0001 < 0.0001
Taï 0.1284 0.1948 – 0.7626 < 0.0001 < 0.0001
Tchimpounga 0.1915 0.3008 1 – 0.0003 < 0.0001
Gombe 0.0040 0.0083 0.3812 0.3458 – 0.0376
Kibale 0.7601 1 0.0428 0.0644 < 0.0001 –
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genetic bottleneck compared to western chimpanzees (Fischer
et al. 2006; Fischer et al. 2011; Prado-Martinez et al. 2013).
This suggests that rather than demography, the differences in
MHC-B exon two diversity and MHC-B-C1 epitope frequen-
cymight be better explained by a selective processes mediated
by pathogens given the importance of this gene in immune
function. TheMHC diversity of both studied chimpanzee pop-
ulations from the Taï and the Kibale National Parks could be
affected by pathogen exposure in their past. In addition to the
confrontation with several respiratory diseases which affected
both studied populations, western chimpanzees from Taï also
experienced severe Ebola outbreaks (Emery Thompson et al.
2018; Formenty et al. 1999; Hoffmann et al. 2017; Köndgen
et al. 2008; Leendertz et al. 2017; Negrey et al. 2019; Scully
et al. 2018). This potential higher pathogenic load in this pop-
ulation could be responsible for the selection of higherMHC-
B exon two diversity. However, contradicting this very sim-
plified hypothesis is the low MHC-B diversity in eastern
Gombe chimpanzees which might also experience a high
pathogenic load caused by SIV (Wroblewski et al. 2015).
Another explanation for the differences in MHC-B exon two
diversity between western and eastern chimpanzees could be
the reduction of diversity in eastern chimpanzees caused by
certain pathogens in their evolutionary past; however, finding
a suitable pathogen candidate is too speculative.
Equally difficult to explain is the reduction of the MHC-B-
C1 epitope frequency in eastern chimpanzees. Again, a selec-
tive process by pathogens could be reasonable as the interac-
tion of KIR epitopes with KIR genes on NK cells is of similar
importance for effective immune functionality as the presen-
tation of antigens by MHCmolecules to T cells. However, the
reduction of the MHC-B-C1 epitope frequency of eastern
chimpanzees could be simply a by-product of selection driv-
ing the increase in frequency of certainMHC-B alleles, which
by chance are not coding for the MHC-B-C1 epitope. This is
supported by the fact that the complete loss of the C1 epitope
at MHC-Bmolecules (MHC-B-C1) might not severely reduce
the ability of an individual to interact with KIRs as the C1
epitope is still present on some MHC-C molecules (MHC-C-
C1) in eastern chimpanzees. In this regard, it would be very
interesting to analyze if there exist differences between west-
ern and eastern chimpanzees in the presence and frequency of
the particular KIR genes which allow the interaction with the
C1 epitope, as was done in the comparisons between chim-
panzees and bonobos (Rajalingam et al. 2001; Wroblewski
et al. 2019).
In sum, in this present study, we describe differences in
MHC-B exon two diversity and the frequency of KIR epitopes
between populations of western and eastern chimpanzees
which are likely not the result of differences in overall genetic
diversity and population genetic history between the popula-
tions but rather represent the outcome of selective processes
mediated by different pathogen pressures. To extend this
work, intensive studies are needed investigating the natural
pathogen environments and pathogen threats of wild living
chimpanzee communities and populations which might pro-
vide insights into the selective forces causing the differences
seen in MHC diversity between chimpanzee subspecies, pop-
ulations, and communities.
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